CRHF Crome Implantable Cardioverter Defibrillators: a recall — FDA Z-1489-2022
There is the potential for reduced shock energy (~79% of programmed energy) during high-voltage (HV) therapy for Cobalt and Crome implantable cardioverter defibrillators (ICDs) and cardiac…